Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity.
about
Gene therapy for carcinoma of the breast: Genetic immunotherapyTrial watch: Dendritic cell-based anticancer therapyDendritic cells reconstituted with human telomerase gene induce potent cytotoxic T-cell response against different types of tumorsIndirect recruitment of a CD40 signaling pathway in dendritic cells by B7-DC cross-linking antibody modulates T cell functions.Photodynamic therapy induces interleukin secretion from dendritic cells.Role of dendritic cells in the induction and maintenance of autoimmune diseases.Dendritic cell migration limits the duration of CD8+ T-cell priming to peripheral viral antigen.Overexpression of sonic Hedgehog in the lung mimics the effect of lung injury and compensatory lung growth on pulmonary Sca-1 and CD34 positive cellsCD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells.New technologies toward dendritic cell-based cancer immunotherapies.Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination.Virus-receptor mediated transduction of dendritic cells by lentiviruses enveloped with glycoproteins derived from Semliki Forest virusFeeding dendritic cells with tumor antigens: self-service buffet or à la carte?Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells.Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.Trends in cancer immunotherapyProtective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product.Recent advances in dendritic cell vaccines for cancer treatment.Production of lentiviral vectors with enhanced efficiency to target dendritic cells by attenuating mannosidase activity of mammalian cells.Adenovirus-based vaccine with epitopes incorporated in novel fiber sites to induce protective immunity against Pseudomonas aeruginosaResponses of cancer cells induced by photodynamic therapy.Spinning molecular immunology into successful immunotherapy.Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunityToxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection.Genetic medicine strategies to protect against bioterrorism.Immunization with adenoviral-vectored tick salivary gland proteins (SALPs) in a murine model of Lyme borreliosis.In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responsesGenetically modified dendritic cells--a new, promising cancer treatment strategy?Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells.Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth.Pseudotyping lentiviral vectors with aura virus envelope glycoproteins for DC-SIGN-mediated transduction of dendritic cells.Prolonged expression of MHC class I - peptide expression in bone marrow derived retrovirus transfected matured dendritic cells by continuous centrifugation in the presence of IL-4.In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer.Novel dendritic cell-based vaccination in late stage melanomaProgress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes.Antigen-pulsed dendritic cells expressing macrophage-derived chemokine elicit Th2 responses and promote specific humoral immunity.Therapeutic potential of dendritic-based vaccines.Activation of antigen-presenting cells by DNA delivery vectors.Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.
P2860
Q24797848-694BC621-9AAC-4E3D-AF9B-2187DC500BB8Q27024047-6F238AD1-3954-4C07-883A-27735378078AQ28183577-E8DBBFC4-95F2-4F9C-A40E-3733A3DEE17CQ30862052-0B173879-625A-4627-B3C1-BB1A9A4C6985Q33626420-A1C76647-C02B-45A0-BC1F-242713EEC459Q33713274-A172F35B-0E30-4622-B95D-30F43563C94AQ33725752-7D519B14-DE20-4963-9477-68277155ACD2Q33730722-AE2C7BE9-544F-4FD7-973D-F514AEE8AF2CQ33810726-C5DC96DC-2677-43C3-8606-948043D47280Q33817903-60088F4A-897E-47DD-8E7B-895BB942738BQ33825567-6F08E627-6218-4894-86EA-30491ECBA323Q33954953-6078F39E-EC9C-4B12-9AC6-063AB5056A0DQ33986125-D7EE05B5-7985-4A03-9FFD-FD292AC823B3Q34008325-3455CB14-A050-441B-B214-F0975818CEA0Q34033557-9C016F3A-D26E-41FA-9C49-58F173A201A5Q34052702-CE976B01-3FE0-419D-AD5D-30CDE32B69F6Q34123275-6F2FCE90-AC5E-481E-9D88-4511778A8B00Q34333200-83E9F0A0-6CC8-468A-944A-7D701151ACC5Q34480504-DA7E91B1-E0A4-4500-95AC-F386BEE2CAB7Q34576498-9753DB1C-A914-474D-BCB2-C517566705ADQ34599868-D2D136BF-993C-4F92-9085-B5A8219BE996Q34624384-927DF047-C46D-4208-B365-B6A2B952D122Q34632056-118CC77E-A9DA-4AB6-9147-39BE8E15B5B1Q34648154-499E5FA9-77CD-4DFF-8B50-B6F5C7FAA5ABQ34756786-6B89B94C-D177-48C2-9F5F-F44C0C6B6B84Q34767181-E14D993E-7E4B-4DF0-8E93-81AC9C106F3BQ35013118-A667F2A5-5133-47B4-B1E6-E7EECBDB06FBQ35019317-1C811DD1-DA59-45B4-8FBE-85F884F27D56Q35040829-05CA1A36-FE58-482E-A64D-6906D4235A9EQ35079643-6FDED5E1-0597-42CB-B4BD-2BD491A3F4BCQ35159565-DC65F958-84F5-4F08-A809-5216F3EA2F0AQ35496414-DF4CDC77-D952-4E5C-8F69-CB8A6E0C3C6DQ35646910-A0E101D9-10E2-403B-9BEB-2D8E02A5F3D2Q35752100-BD1F3B6F-D258-47D2-B047-7D6CD9D6F5EAQ35886439-03FFB455-80F8-4876-B6F0-100232D04D7EQ35922431-AEB846E1-80B5-44C1-9AB0-555C27CFF058Q36041103-46CB11F4-C9DE-4AB5-949B-79ED9ADB1F33Q36181313-FF3F66AF-82D9-4EA8-AC1A-4A4255649AA0Q36210847-E3504DD3-9827-4C91-B849-AA85531E8E81Q36315185-3371177C-1449-4492-AA7F-7B44853CBE25
P2860
Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Dendritic cells genetically mo ...... herapeutic antitumor immunity.
@ast
Dendritic cells genetically mo ...... herapeutic antitumor immunity.
@en
type
label
Dendritic cells genetically mo ...... herapeutic antitumor immunity.
@ast
Dendritic cells genetically mo ...... herapeutic antitumor immunity.
@en
prefLabel
Dendritic cells genetically mo ...... herapeutic antitumor immunity.
@ast
Dendritic cells genetically mo ...... herapeutic antitumor immunity.
@en
P2093
P2860
P356
P1476
Dendritic cells genetically mo ...... herapeutic antitumor immunity.
@en
P2093
H Carpenter
R G Crystal
R Granstein
P2860
P304
P356
10.1084/JEM.186.8.1247
P407
P577
1997-10-01T00:00:00Z